GlassScriptPhysician profile
Brad A Starkey
NPI 1497739437
$7,722.34
in general payments reported to CMS, 2019-2025
36 companies · $1,759 in 2025
The $1,759 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $405 · 2021: $1,270 · 2022: $1,049 · 2023: $959 · 2024: $1,455 · 2025: $1,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,172.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,875.09 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Saluda Medical Americas, INC. | $901.50 | 2023-2025 | Evoke, Evoke Scs |
| Nevro Corp. | $699.10 | 2019-2024 | Senza |
| Boston Scientific Corporation | $682.38 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $592.34 | 2021-2022 | |
| Averitas Pharma INC. | $575.03 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $379.34 | 2019-2025 | Belbuca, Xtampza |
| Medtronic USA, INC. | $299.36 | 2019-2020 | |
| Grt US Holding, INC. | $267.43 | 2021-2022 | |
| Si-Bone, INC. | $183.46 | 2024 | |
| Scilex Pharmaceuticals INC. | $164.27 | 2019-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.17 | 2019-2025 | Relistor |
| Globus Medical, INC. | $95.88 | 2025 | Senza |
| Abbvie INC. | $85.37 | 2021-2023 | Ubrelvy |
| Merck Sharp & Dohme LLC | $78.98 | 2019-2023 | Belsomra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $74.30 | 2019 | |
| Eisai INC. | $68.02 | 2020-2022 | |
| Ucb, INC. | $66.43 | 2025 | Bimzelx |
| Biodelivery Sciences International, INC. | $55.82 | 2019-2021 | |
| Tersera Therapeutics LLC | $55.09 | 2019-2020 | |
| Indivior INC. | $52.69 | 2019-2021 | |
| Pfizer INC. | $48.13 | 2019 | |
| Redhill Biopharma INC. | $30.70 | 2020 | |
| Kaleo, INC. | $28.25 | 2019 | |
| Baudax Bio INC. | $22.54 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.61 | 2024 | |
| Bioventus LLC | $19.50 | 2021 | |
| Amgen INC. | $18.05 | 2020 | |
| Convatec INC. | $16.84 | 2023 | |
| Almatica Pharma LLC | $16.18 | 2021 | |
| Sentynl Therapeutics, INC. | $15.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.18 | 2021 | |
| Valinor Pharma, LLC | $15.05 | 2025 | Movantik |
| Arbor Pharmaceuticals, INC. | $14.22 | 2020 | |
| Azurity Pharmaceuticals, INC. | $14.16 | 2024 | Horizant |
| Astrazeneca Pharmaceuticals LP | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Starkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.